Gustavo A. Rosario Benitez

Array ( [id] => 9589555 [patent_doc_number] => 08779095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'LAT adapter molecule for enhanced T-cell signaling and method of use' [patent_app_type] => utility [patent_app_number] => 13/319263 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 22558 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613194 [patent_doc_number] => 20100310453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'HETEROLOGOUS ANTIBODIES WHICH BIND HUMAN CD4' [patent_app_type] => utility [patent_app_number] => 12/770402 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 99 [patent_figures_cnt] => 99 [patent_no_of_words] => 85103 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310453.pdf [firstpage_image] =>[orig_patent_app_number] => 12770402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228816 [patent_doc_number] => 20100183554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Anti-CD3 Antibodies and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/750385 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21798 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183554.pdf [firstpage_image] =>[orig_patent_app_number] => 12750385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669557 [patent_doc_number] => 20110318826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'INOTROPIC ANTIBODIES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/750617 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15264 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12750617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134428 [patent_doc_number] => 20110008330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Compositions and methods of tolerizing a primate to an antigen' [patent_app_type] => utility [patent_app_number] => 12/660881 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 14523 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008330.pdf [firstpage_image] =>[orig_patent_app_number] => 12660881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095277 [patent_doc_number] => 20110002918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'METHODS OF TREATING DISEASED TISSUE' [patent_app_type] => utility [patent_app_number] => 12/718830 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10659 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 96 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002918.pdf [firstpage_image] =>[orig_patent_app_number] => 12718830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6126688 [patent_doc_number] => 20110086416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'IMMUNOTOXIN FUSION PROTEINS AND MEANS FOR EXPRESSION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/718673 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 57891 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086416.pdf [firstpage_image] =>[orig_patent_app_number] => 12718673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430965 [patent_doc_number] => 20100143357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Uses of Mammalian Cytokine; Related Reagents' [patent_app_type] => utility [patent_app_number] => 12/709162 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19638 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143357.pdf [firstpage_image] =>[orig_patent_app_number] => 12709162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262469 [patent_doc_number] => 20100297107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'HMGB1 PROTEIN INHIBITORS AND/OR ANTAGONISTS FOR THE TREATMENT OF VASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/707264 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6582 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297107.pdf [firstpage_image] =>[orig_patent_app_number] => 12707264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6626611 [patent_doc_number] => 20100172896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'HMGB1 PROTEIN INHIBITORS AND/OR ANTAGONISTS FOR THE TREATMENT OF VASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/707222 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6598 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172896.pdf [firstpage_image] =>[orig_patent_app_number] => 12707222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11177984 [patent_doc_number] => 09409969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => 'Repertoire of allo-restricted peptide-specific T cell receptor sequences and use thereof' [patent_app_type] => utility [patent_app_number] => 13/148653 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10047 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289946 [patent_doc_number] => 20100158922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Anti-Interferon Gamma Antibodies and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/702013 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25174 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158922.pdf [firstpage_image] =>[orig_patent_app_number] => 12702013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519054 [patent_doc_number] => 20100203049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Interleukin-10 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/701386 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21960 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203049.pdf [firstpage_image] =>[orig_patent_app_number] => 12701386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320189 [patent_doc_number] => 20100196311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 12/687650 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11336 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196311.pdf [firstpage_image] =>[orig_patent_app_number] => 12687650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412524 [patent_doc_number] => 20100166754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Methods and Compositions For Treating Autoimmune Diseases or Conditions' [patent_app_type] => utility [patent_app_number] => 12/649938 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18223 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166754.pdf [firstpage_image] =>[orig_patent_app_number] => 12649938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420651 [patent_doc_number] => 20100150947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'TOLERANCE INDUCTION AND MAINTENANCE IN HEMATOPOIETIC STEM CELL ALLOGRAFTS' [patent_app_type] => utility [patent_app_number] => 12/639534 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 21925 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150947.pdf [firstpage_image] =>[orig_patent_app_number] => 12639534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038404 [patent_doc_number] => 20110091453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'METHODS OF ADMINISTERING/DOSING CD2 ANTAGONISTS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISORDERS OR INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/633407 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66382 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091453.pdf [firstpage_image] =>[orig_patent_app_number] => 12633407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857304 [patent_doc_number] => 08883500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy' [patent_app_type] => utility [patent_app_number] => 13/133121 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27066 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615039 [patent_doc_number] => 20100310533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/617018 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12657 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310533.pdf [firstpage_image] =>[orig_patent_app_number] => 12617018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401462 [patent_doc_number] => 08691514 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Method for selective control of helper T cell function' [patent_app_type] => utility [patent_app_number] => 13/126140 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 11506 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126140 [rel_patent_id] =>[rel_patent_doc_number] =>)